Cantwell Wayne C has reported the acquisition of 5,000 shares of Arteris, Inc. This transaction occurred on November 4, 2026, and is significant as it demonstrates Cantwell's continued commitment to investing in the semiconductor sector.

Arteris, Inc., a company focused on semiconductor technology, is the issuer of the shares involved in this transaction. The company is based in Campbell, California, and operates under the SIC classification for semiconductors and related devices.

According to the SEC filing, Cantwell acquired these shares at a price of $0.60 per share, bringing his total ownership to 47,571 shares following this transaction. The filing also indicates that Cantwell holds additional shares through The Cantwell Living Trust and a 401K plan.

This acquisition could affect various stakeholders, including shareholders of Arteris, Inc. and competitors in the semiconductor industry. As Cantwell continues to increase his stake in the company, it may signal confidence in Arteris' future prospects.

The filing does not say what happens next.

Details of the Transaction

The acquisition of 5,000 shares of Arteris, Inc. was executed through a non-qualified stock option, which Cantwell exercised at a price of $0.60 per share. This option was set to expire on April 22, 2030, and was originally granted with a vesting schedule of 36 equal monthly installments starting from May 23, 2020.

Following this transaction, Cantwell's total ownership of shares in Arteris, Inc. now stands at 65,000 shares, which includes the newly acquired shares and shares held through the Decathlon Capital Management 401K Plan and The Cantwell Living Trust.

Ownership Structure

The filing outlines that Cantwell Wayne C is a director of Arteris, Inc. but does not hold an officer position or own more than 10% of the company's stock. The shares held through The Cantwell Living Trust indicate a significant personal investment in the company, as Cantwell serves as the trustee for this trust.

The shares are held by The Cantwell Living Trust, for which the Reporting Person serves as trustee.

This acquisition further solidifies Cantwell's involvement in Arteris, Inc., potentially influencing future strategic decisions within the company.